ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,201.60
1.67%
S&P ASX All Technology
3,829.30
1.67%
Brent Oil
72.355
-0.50%
US Dollar vs AUD
1.60498
0.35%
Bitcoin
95,183.90
0.08%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Hims and Hers Health Inc (HIMS) Share Price

Hims and Hers Health Inc

Hims and Hers Health Inc (HIMS)

NYSE
26.20
-0.16
(-0.61%)
Closed 21 December 8:00AM
Delayed by 15 minutes
26.5001
0.3001
( 1.15% )
Pre Market: 12:54AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
26.5001
Bid
-
Offer
-
Volume
514,884
0.00 Day's Range 0.00
8.09 52 Week Range 35.02
Market Cap
5.79B
Previous Close
26.20
Open
-
Last Trade
30
@
26.5
Last Trade Time
00:57:53
Financial Volume
-
VWAP
-
Average Volume (3m)
17,251,018
Shares Outstanding
218,479,114
Dividend Yield
-
PE Ratio
-243.04
Earnings Per Share (EPS)
-0.11
Revenue
872M
Net Profit
-23.55M

About Hims and Hers Health Inc

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Sector
Offices Of Medical Doctors
Industry
Blank Checks
Website
www.hims.com
Headquarters
Dover, Delaware, USA
Founded
2021
Hims and Hers Health Inc is listed in the Offices Of Medical Doctors sector of the New York Stock Exchange with ticker HIMS. The last closing price for Hims and Hers Health was US$26.20. Over the last year, Hims and Hers Health shares have traded in a share price range of US$ 8.09 to US$ 35.02.

Hims and Hers Health currently has 218,479,114 shares in issue. The market capitalisation of Hims and Hers Health is US$5.72 billion. Hims and Hers Health has a price to earnings ratio (PE ratio) of -243.04.

Ask ADVFN Intelligence (AI)

Hims and Hers Health (HIMS) Options Flow Summary

HIMS Options Flow

Overall Flow

Bearish

Net Premium

-328k

Calls / Puts

88.00%

Buys / Sells

45.16%

OTM / ITM

34.29%

Sweeps Ratio

2.13%

HIMS Latest News

More News

Form 144 - Report of proposed sale of securities

21 December 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

20 December 2024
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.9249-9.9401869158929.42533.1424.621700590528.00308089CS
4-0.9649-3.5131986164227.46535.0224.621636931630.51732085CS
128.630148.293788472317.8735.0216.051725101824.34903886CS
264.480120.345594913722.0235.0213.471254831422.14525878CS
5217.8501206.3595375728.6535.028.09981034519.86760293CS
15620.0401310.2182662546.4635.022.72490976015.60201834CS
26010.050161.094832826716.4535.022.72428360914.98628822CS

HIMS - Frequently Asked Questions (FAQ)

What is the current Hims and Hers Health share price?
The current share price of Hims and Hers Health is US$ 26.5001
How many Hims and Hers Health shares are in issue?
Hims and Hers Health has 218,479,114 shares in issue
What is the market cap of Hims and Hers Health?
The market capitalisation of Hims and Hers Health is USD 5.72B
What is the 1 year trading range for Hims and Hers Health share price?
Hims and Hers Health has traded in the range of US$ 8.09 to US$ 35.02 during the past year
What is the PE ratio of Hims and Hers Health?
The price to earnings ratio of Hims and Hers Health is -243.04
What is the cash to sales ratio of Hims and Hers Health?
The cash to sales ratio of Hims and Hers Health is 6.56
What is the reporting currency for Hims and Hers Health?
Hims and Hers Health reports financial results in USD
What is the latest annual turnover for Hims and Hers Health?
The latest annual turnover of Hims and Hers Health is USD 872M
What is the latest annual profit for Hims and Hers Health?
The latest annual profit of Hims and Hers Health is USD -23.55M
What is the registered address of Hims and Hers Health?
The registered address for Hims and Hers Health is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
What is the Hims and Hers Health website address?
The website address for Hims and Hers Health is www.hims.com
Which industry sector does Hims and Hers Health operate in?
Hims and Hers Health operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DESPDespegar com Corp
US$ 19.47
(32.90%)
708.54k
AKRAcadia Realty Trust
US$ 29.89
(25.12%)
69
BKNBlackRock Investment Quality Muni
US$ 13.99
(24.02%)
2
CHNChina Fund Inc
US$ 14.99
(23.68%)
11
OECOrion SA
US$ 18.99
(22.20%)
283
AFBAllianceBernstein National Municipal Income Fund Inc
US$ 9.01
(-17.87%)
1
BHRBraemar Hotels and Resorts Inc
US$ 2.71
(-16.36%)
145
IVTInvenTrust Properties Corporation
US$ 25.01
(-16.07%)
10
MIOPioneer Municipal High Income Opportunities Fund Inc
US$ 10.01
(-15.74%)
1
KKRSKKR Group Finance Co IX LLC
US$ 16.01
(-15.16%)
212
QBTSD Wave Quantum Inc
US$ 7.82
(21.43%)
9.63M
BBAIBigBear ai Holdings Inc
US$ 3.22
(3.54%)
2.41M
IONQIonQ Inc
US$ 45.75
(2.99%)
1.87M
NIONIO Inc
US$ 4.54
(0.00%)
1.42M
ACHRArcher Aviation Inc
US$ 9.82
(3.48%)
1.34M

HIMS Discussion

View Posts
fung_derf fung_derf 4 days ago
Sharectile dysfunction? It can only stay up for so long.
👍️0
infamous infamous 4 days ago
hows is this 16% down premarket already today? what gives?
👍️0
Monksdream Monksdream 2 weeks ago
HIMS, just under the 52 week high
👍️0
a surfer a surfer 3 weeks ago
My luck was not paying attention to it too diligently...lol
👍️ 1
fung_derf fung_derf 3 weeks ago
I sold too soon, but to be fair, it already looks pricey.
👍️0
a surfer a surfer 3 weeks ago
Been one hell of a run. I took a few off. Been holding most from $6
👍️0
fung_derf fung_derf 3 weeks ago
Well, it sure hit $32 quickly enough. Now do we see the big breakout, or pullback? I should have taken my own advice here...

If you had played this stock right, it would have made for a nice roller coaster. I rode it once from $13 to $19. It looks like the next stop may be around $32.
Of course it is also the epitome of a high risk stock.
👍️0
Monksdream Monksdream 4 weeks ago
HIMS, new 52 week high
👍️0
PonkenPlonken PonkenPlonken 4 weeks ago
I wish for a world in which they are able to punish these laughable selloffs on some lukewarm excuse...
As seen in ADMA, HOOD, TSLA and here. Technically its fine... Practically what they are doing is an orchestrated maneuver to scam gullible investors living on buy/sell panic diet
👍️0
Monksdream Monksdream 1 month ago
HIMS new 52 week high
👍️0
Monksdream Monksdream 2 months ago
HIMS 10Q 11/4
👍️0
Dennisb68 Dennisb68 2 months ago
IKT is having a fantastic run!
👍️0
fung_derf fung_derf 2 months ago
If you had played this stock right, it would have made for a nice roller coaster. I rode it once from $13 to $19. It looks like the next stop may be around $32.
Of course it is also the epitome of a high risk stock.
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
Wow
👍️0
Monksdream Monksdream 3 months ago
Good morning! In the latest GLP-1 news, the FDA reported last week that Eli Lilly’s weight loss and diabetes drug Mounjaro is no longer facing a shortage. This means pharmacy companies that have been compounding the medication, a process that uses the same ingredients and is only allowed in times of shortages, can no longer do so. Novo Nordisk’s Ozempic and Wegovy are not affected by this, and will likely continue to be distributed by compounding pharmacies, including Hims and Hers.
👍️0
Monksdream Monksdream 3 months ago
HIMS YTD
👍️0
Monksdream Monksdream 5 months ago
HIMS 10Q due AUGUST5
👍️0
Monksdream Monksdream 6 months ago
HIMS under $25
👍️0
r clarke r clarke 6 months ago
HIMS selling compounded GLP-1 despite the FDA warnings.
Compounding is allowed during shortages, but there may be issues with supplier?
Compounded drug is not FDA tested or approved.
Possible short candidate if it heads higher?
👍️0
Monksdream Monksdream 6 months ago
HIMS new 52 week high
👍️0
Monksdream Monksdream 6 months ago
HIMS new 52 week high
👍️0
Monksdream Monksdream 7 months ago
HIMS new 52 week high
👍️0
Dennisb68 Dennisb68 7 months ago
God Bless Israel!
👍️0
Dennisb68 Dennisb68 7 months ago
God Bless Israel.
👍️0
Dennisb68 Dennisb68 7 months ago
Just sold my shares after learning about the dirt bag CEO. Hope the company tanks.
👍️0
trendzone trendzone 7 months ago
Share holders woke up to limp one, will have to take some viagra to get a pump.
👍️0
bikaver bikaver 7 months ago
HIMS..... From 16.21 to 20.45 in five days is good enough for me. Adios and GLTA
👍️0
Monksdream Monksdream 7 months ago
HIMS new 52 week high
👍️0
bikaver bikaver 7 months ago
HIMS.....
👍️0
trendzone trendzone 7 months ago
It's selling off on being down graded, you would have to be a total fool selling $15 puts at $0.05.
👍️0
Monksdream Monksdream 7 months ago
HIMS new 52 week high
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Greedy G Greedy G 8 months ago
~RIPPn on nice beat
👍️0
Greedy G Greedy G 8 months ago
~bought the 5/10 18.5 calls @.07c
👍️0
trunkmonk trunkmonk 8 months ago
I never bought anything from his company never will. Board membership should be earned, I could care less about entitlement or give aways, but he makes me sick to my stomach in supporting murder of innocent and raping women. I dont care what color of skin they have, innocent women and children should never suffer.
👍️0
trunkmonk trunkmonk 8 months ago
yup
👍️0
trunkmonk trunkmonk 8 months ago
I am going to make an acceptation to my rule, i never directly short any stocks. when the time it right, im gonna short the daylights out of any real weakness in HIMS. He is a POS for making such a statement then doing a 180, 💩
👍️0
Bestbet2020 Bestbet2020 8 months ago
Hope this goes to shit! Couldn't happen to a better company. Sell, or watch you investment go to zero! Woke=Broke
👍️ 1
Porman Porman 8 months ago
Cancelled my recurring prescription with HIMS yesterday. I guess I need to do more DD on who I do business with. Would love to watch this fail on bad earnings today. I wonder how many people did exactly what I just did?
👍️ 2
nickypicky nickypicky 8 months ago
Too late Bud for your apology. You should have been smarter before you stuck your foot in your mouth. We all heard how you really felt. Bud Light em' up. And make sure you guide sales lower in conference call.
👍️0
nickypicky nickypicky 8 months ago
Business Wire press releases are the most inexpensive way to issue a press release. Another eyebrow raiser to me here. I used to do press releases for companies I consulted. If small companies didn't have much of a pr budget we used Business Wire which worked....but if you have a bunch of cash like they supposedly do you crank out the news with much bigger budget. Imo.
👍️0
Monksdream Monksdream 8 months ago
HIMS 10Q due 5/6
T+1 settlement begins 5/28
👍️0
OverDraught OverDraught 8 months ago
Article about $HIMS and Dudum on Fox Business News, 5/5/24:
Dudum Article
👍️0
easymoney easymoney 8 months ago
Shorting this POS is fun $6 would be it imo.
👍️0
OverDraught OverDraught 8 months ago
Dudum's a racist? Well, he does appear to support Hamas, an violent antisemitic terrorist group. And he hasn't put any African Americans on his Board of Directors... So, yeah, you might be right.
👍️0
nickypicky nickypicky 8 months ago
Go racist go broke more like it, IMO.
👍️0
Rutt Rutt 8 months ago
I just sold all my shares in this company. This was the worst move that a CEO could ever make. I had no idea about his ties to radical Islam extremists. I will never invest in anything that this guys is involved with ever again.
👍️ 1
OverDraught OverDraught 8 months ago
Woke = Broke!
Yeah... Dudum did dumb.
👍️0
nickypicky nickypicky 8 months ago
The question now is if the future outlook will be updated on the earnings call?
👍️0
Bestbet2020 Bestbet2020 8 months ago
Guess the Dickhead CEO guessed wrong on this! Woke = Broke!
👍️0
standintall standintall 8 months ago
This won't build support for the stock. Lots of places where one can buy what they're selling.
https://www.foxbusiness.com/politics/hims-founder-offers-jobs-anti-israel-protesters-hails-their-moral-courage
👍️0

Your Recent History

NYSE
HIMS
Hims and Hers Health
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads